← All organizations
Highest phase reached
Phase 3
First clinical trial
May 2, 2018Last known activity
Oct 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT06819592OfficialPhase 3Oct 30, 2025
- NCT03333278CollaboratorPhase 2May 2, 2018
Details
- Last known activity
- Oct 30, 2025